Proyectos de ley › 91.ª Asamblea General
Relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees
Presentado por el comité Health and Human Services del Senado
Temas:State governmentHealth careMedicaid
La misma legislación: SSB 1138
Dónde está ahora
- Hecho: Presentado18 de febrero de 2025
- Hecho: Subcomité18 de febrero de 2025
- Hecho: Comité del Senado5 de marzo de 2025
- Se detuvo: Lo aprueba el SenadoMurió al terminar la Asamblea General
- Sigue: Comité de la CámaraEmbudo: antes del 20 de marzo de 2026
- Sigue: Lo aprueba la Cámara
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Murió al terminar la sesión La sesión de 2026 terminó el 3 de mayo de 2026, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?
Qué contiene
Resumen con IA Iowa state agencies will study whether to cover weight-loss drugs, such as GLP-1 agonists, for people on Medicaid or state employee health plans. They will look at how well these medicines work, how much they cost, and who should be allowed to use them. A report with their findings and cost estimates must be given to the state legislature by January 5, 2026. (Todavía no está traducido al español.)1
Lea la explicación oficial (en inglés)
This bill relates to the department of health and human services (HHS) and the department of administrative services (DAS) review of anti-obesity medication for purposes of the medical assistance program and health insurance plans for state employees established pursuant to Code chapter 509A. The bill requires HHS and DAS to review anti-obesity medications, including GLP-1 agonists, for effectiveness, comorbidities, cost savings, eligibility requirements, and short-term and long-term costs associated with coverage. HHS and DAS shall submit a report to the general assembly by January 5, 2026, containing HHS’s and DAS’s findings, proposed eligibility requirements, and any short-term and long-term costs associated with coverage.
Senate subcommittee
Named February 18, 2025 (as SSB 1138). On February 20, 2025 it recommended amendment and passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Cabildeo
2 a favor · 0 en contra · 16 indecisos · Quiénes →
Family tree
Study bill
91st General Assembly